Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

FEMSA - ADR (FMX.N)

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (US$)	Price Target (US$)	Rating
2021-01-18	NaN	76.50	Buy
2021-01-21	74.11	84.00	Buy
2021-03-11	75.63	90.00	Buy
2021-07-29	88.44	105.00	Buy
2022-01-31	75.22	86.00	Neutral
2022-03-21	81.67	88.00	Neutral
2022-10-03	64.14	-	No Rating
2022-10-10	62.90	96.00	Buy
2023-02-13	84.51	113.00	Buy
2023-05-31	100.61	120.00	Buy
2023-07-24	108.02	137.00	Buy
2024-01-11	129.23	150.00	Neutral

Disclosures

UBS expects to receive or intend to seek compensation for investment banking services from this company/entity within the next three months.
UBS Securities LLC makes a market in the securities and/or ADRs of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day.